中医药调节HPA/HPT/HPG轴治疗抑郁症的研究进展
DOI:
作者:
作者单位:

华北理工大学

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(面上项目,重点项目,重大项目)


Research advances in the regulation of HPA/HPT/HPG axis in the treatment of depression in traditional Chinese medicine
Author:
Affiliation:

华北理工大学

Fund Project:

The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    郁症的发病机制复杂、治疗手段局限,阐明其发病机制和开发新的治疗药物具有重要意义。目前,激素和激素操纵化合物已被用于治疗抑郁症,其治疗作用不仅归因于外围内分泌系统的调节,还归因于激素对非内分泌脑回路的中枢神经系统的影响。HPA/HPT/HPG与抑郁症的发病机制关系密切。中医药治疗抑郁症的作用机制广泛,对三条轴的调节也呈现出多种方式。本文基于激素和激素操纵子化合物参与抑郁症的病理学和治疗的新证据,对当前中医药治疗抑郁症的相关机制进行了归纳,以期为今中医药研究提供思路和借鉴。

    Abstract:

    The pathogenesis of depression is complex and the treatment methods are limited, and it is of great significance to clarify its pathogenesis and develop new therapeutic drugs. Currently, hormones and hormone-modifying compounds have been used to treat depression, and their therapeutic effects are attributed not only to the regulation of the peripheral endocrine system, but also to the effects of hormones on the central nervous system of non-endocrine brain circuits. HPA/HPT/HPG is closely related to the pathogenesis of depression. The mechanism of action of traditional Chinese medicine in the treatment of depression is extensive, and the regulation of the three axes also presents a variety of ways. Based on the new evidence of hormones and hormone operon compounds involved in the pathology and treatment of depression, this paper summarizes the relevant mechanisms of current traditional Chinese medicine in the treatment of depression, in order to provide ideas and references for the research of traditional Chinese medicine.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-02-23
  • 最后修改日期:2024-10-20
  • 录用日期:2024-12-16
  • 在线发布日期:
  • 出版日期:
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭